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RESEARCH NOTE
Measuring the health-related quality 
of life of children with impaired mobility: 
examining correlation and agreement 
between children and parent proxies
Nathan Bray1*, Jane Noyes2, Nigel Harris3 and Rhiannon Tudor Edwards1
Abstract 
Objective: The objective of this research project was to evaluate the validity of proxy health-related quality of life 
measures in the context of paediatric mobility impairment. Accurate health-related quality of life data is essential for 
quality-adjusted life year calculation; a key outcome in economic evaluation. Thirteen child-parent dyads (13 children 
with mobility impairments, 13 parent proxies) were asked to complete a range of outcome measures (EQ-5D-Y, VAS 
and HUI2/3) relating to the child’s health. The relationship between respondent outcomes was examined using tests 
of respondent type effect (Wilcoxon signed-rank), correlation (Spearman’s rank-order) and agreement (Bland–Altman 
plots).
Results: Parent proxies significantly undervalued the health-related quality of life of their mobility-impaired children: 
children rated their health-related quality of life higher than their parents by proxy on all measures. The VAS had the 
highest overall mean score for children and proxies (79.50 [SD = 15.01] and 75.77 [SD = 14.70] respectively). Child 
and proxy results were significantly different (p < 0.05) for all measures besides the VAS (p = 0.138). Strong correlation 
and acceptable agreement were observed for equivalent child/proxy VAS and HUI measures. The EQ-5D-Y exhibited 
the least agreement between children and proxies. Sufficient association between child/proxy VAS and HUI measures 
indicated a degree of interchangeability.
Keywords: Mobility impairment, Childhood disability, Wheelchair, Assistive technology, Health economics, Health-
related quality of life
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publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Preference-based measures of health-related quality of 
life (HRQoL) are used to assess the utility gains associ-
ated with clinical, social care and public health interven-
tions. Utility refers to the subjective level of wellbeing 
experienced in different states of health [1]. Each poten-
tial health state is assigned a utility weight derived from 
the social desirability of that state, for instance ranging 
from death to perfect health [2]. The most commonly 
used measure of utility is the quality adjusted life-year 
(QALY), which is an aggregate of both quantity and qual-
ity of life. In order to calculate QALYs preference-based 
HRQoL data is required.
HRQoL is a subjective and multi-dimensional con-
struct defined as the perceived impact of health status on 
quality of life, including physical, psychological and social 
functioning [3]. Definitions of paediatric HRQoL must 
take into account the unique social contexts of child-
hood, including family, friends and school [4].
Standard measures of HRQoL, such as the EQ-5D [5] 
and Health Utilities Index (HUI) [6], are supported by a 
wealth of validation literature and value sets to ascribe 
weights to utility functions [5–10].
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In paediatric research it is common place for parents 
and/or carers to report outcomes on behalf of their child 
when age, ability or capacity precludes inclusion of the 
child directly. However, proxy reports are often signifi-
cantly different to self-reports, particularly for children 
with disabilities [11, 12]. Understanding the relationship 
between child self-reported data and parental proxy data 
is important to assess the relative validity of different 
sources of data in economic analyses [13].
Previous research has demonstrated the holistic 
benefits of wheelchairs for children, however there is 
practically no evidence to demonstrate the relative cost-
effectiveness of paediatric wheelchair provision [14]. To 
facilitate future economic evaluations in this context, 
there is a  need to understand how best to measure the 
HRQoL of children with mobility impairments.
The overarching aim of this pilot study was to compare 
how children with mobility impairments and their par-
ents (by proxy) report HRQoL using standard outcome 
measures. Our secondary  objective was to determine if 
there are statistically significant differences between the 
self-reported outcomes of children with mobility impair-
ments and the proxy-reported outcomes of their parents.
Data were collected as part of a Ph.D. studentship pro-
gramme of research. Other findings from the project 
have been published elsewhere [14–16].
Methods
Sampling and recruitment
Inclusion and exclusion criteria are presented in Table 1. 
The sampling frame comprised dyads of children with 
mobility impairments (aged 18 or under; hereafter 
referred to as ‘children’) and one of their parents. Partici-
pants were offered a small financial incentive (a £10 retail 
voucher) for taking part in the study. Children under the 
age of 16 completed an assent form and their parents 
completed a proxy consent form. A sample size calcu-
lation was not undertaken due to the small scale of the 
pilot.
Participants were recruited between June and October 
2013 from two UK recruitment sites: a Welsh National 
Health Service (NHS) wheelchair service and a children’s 
wheelchair charity based in England.
Data were collected using postal questionnaire sur-
veys. Questionnaires contained outcome measures (EQ-
5D-Y, HUI, VAS) and demographic questions. Child 
questionnaires contained self-administered versions of 
measures, while parent questionnaires contained proxy 
versions.
Measures
The EQ-5D-Y is a validated HRQoL measure for use in 
children and parent proxies [17]. A pre-existing UK gen-
eral adult population value set was used to assign weights 
for domain levels, on a death to perfect health scale (0 to 
1) [7]. At present there are no specific value sets for chil-
dren or parent proxies.
The HUI is a validated HRQoL measure containing the 
HUI2 and HUI3 systems [6]. Multi-attribute utility func-
tions were used to assign utility scores to HUI2/3 attrib-
ute levels, on a death to perfect health scale (0 to 1) [9, 
10]. Both the EQ-5D-Y and HUI measures have health 
states considered worse than death, and thus some states 
can have negative values.
The VAS (EQ-VAS) is typically presented alongside the 
EQ-5D-Y, and measures self-rated health status on a scale 
from worst imaginable to best imaginable health (0 to 
100). In order to aid comparison with the EQ-5D-Y and 
HUI measures the VAS scoring system was converted 
from a 0 to 100 scale to a 0 to 1 scale during certain 
analyses.
Analyses
Statistical analysis of mean scores All analyses were con-
ducted using SPPS v20. Data were not normally distrib-
uted therefore non-parametric statistical methods were 
used. Wilcoxon signed-rank tests were used to analyse 
statistically significant (p  <  0.05) differences between 
Table 1 Inclusion and exclusion criteria for participants
a  Long term mobility impairment defined as having existed for 6 months or more, or expected to last for 6 months or more
Inclusion criteria Exclusion criteria
Children and young people with long term (>6 monthsa) mobility impair-
ments
 Aged 5–18 years
 Requires a manual and/or powered wheelchair/pushchair/buggy for the 
purposes of mobility
 Able to give informed consent to take part in study, or able to give assent 
and parent/guardian able to give proxy consent
Parent(s) or legal guardian(s) of a child or young person with a long term 
mobility impairment who uses a wheelchair
 Able to give informed consent to take part in study, and able to give proxy 
consent where required
Any significant social or emotional problems or challenging behaviours 
where such problems in the opinion of the family or clinical team are 
likely to impair participant’s ability to take part in the study or pose a 
risk to the researcher or the participant
Unable to communicate in English or Welsh
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children and parent proxies, based on EQ-5D-Y, VAS and 
HUI total score mean ranks for dyads.
Correlation between children and parent proxies Spear-
man’s rank-order was used to test correlation. Correlation 
was assessed between dyads of child and parent proxy 
total scores to examine whether they were associated. In 
order for child and parent proxy measures to be consid-
ered sufficiently associated, correlation coefficients had 
to be defined as moderate or strong (rs of <0.20 = absent; 
rs of 0.20 to 0.35 = weak; rs of 0.35 to 0.50 = moderate; rs 
of ≥0.50 = strong) [18].
Agreement between children and parent proxies 
Bland–Altman plots were used to assess agreement 
between children and parent proxy results. On the plot 
95% of differences should lie between the established 
limits of agreement (mean difference ± 1.96 SD) [19], 
represented as dashed lines. Where bias or limits of 
agreement are beyond those deemed acceptable for 
clinical use, the measures lack agreement to be used 
interchangeably to measure the same construct. A 
confidence limit of 0.50 was chosen.
Results
Response rate, sample size and missing data
Study invitation packs were sent to 64 eligible chil-
dren and their parents. In total 28 questionnaires were 
returned; 15 child participants and 13 parent proxies. 
Two child participants returned questionnaires with-
out parent proxy data, and thus were excluded from the 
dyad analyses. This provided a full sample of 13 dyads 
of children and their parents. Data from two dyads were 
excluded from the EQ-5D-Y analyses due to incomple-
tion of the measure, giving an overall completion rate of 
84.6% for this measure. All other measures were com-
pleted in full without error or missing data. Demographic 
details for the dyads of children and parents are pre-
sented in Table 2.
HRQoL total score results
Descriptive statistics are presented in Table 3. The overall 
mean scores on all of the measures were higher for child 
self-reports than for parent proxies (see Fig. 1). The VAS 
had the highest overall mean score for children and par-
ent proxies (79.50 [SD = 15.01] and 75.77 [SD = 14.70] 
Table 2 Demographic characteristics of  dyads of  children 
with mobility impairments and parents
Demographic characteristics Number (%)
Study site
 NHS Wheelchair Service 2 (15.4)
 Wheelchair charity 11 (84.6)
Parent gender
 Female 12 (92.3)
 Male 1 (7.7)
Parent age
 30–39 years 3 (23.1)
 40–49 years 8 (61.5)
 50–59 years 2 (15.4)
Parent ethnicity
 White British 13 (100)
Parent education
 Higher 4 (30.7)
 Further (e.g. a level) 2 (15.4)
 GCSE/O level 2 (15.4)
 Other 3 (23.1)
 None 2 (15.4)
Annual household income
 £5000–£15,000 1 (7.7)
 £16,000–£25,000 1 (7.7)
 £26,000–£35,000 1 (7.7)
 £36,000–£50,000 6 (46.2)
 £51,000–£75,000 2 (15.4)
 £75,000 or more 1 (7.7)
 Missing 1 (7.7)
Parent employment status
 Full-time 1 (7.7)
 Part-time 6 (46.2)
 Unemployed 6 (46.2)
Child’s condition
 Cerebral palsy 11 (84.6)
 Hemiplegia/stroke 1 (7.7)
 Muscular dystrophy 1 (7.7)
Child age
 6–15 years 7 (58.8)
 16–18 years 6 (46.2)
Child gender
 Female 5 (38.5)
 Male 8 (61.5)
Child education
 Primary school 2 (15.4)
 High school 5 (38.5)
 College 4 (30.7)
 University 1 (7.7)
 Home schooled 1 (7.7)
Frequency of child’s equipment use
 Most of the time 2 (15.4)
 All of the time 11 (84.6)
% refers to the percentage of research participants
Table 2 continued
Demographic characteristics Number (%)
Type of equipment used by child
 Manual 4 (33.3)
 Manual and EPIOC 9 (66.7)
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respectively), followed by the HUI2 (0.53 [SD = 0.07] and 
0.49 [SD = 0.09] respectively). Children scored the EQ-
5D-Y higher than the HUI3 (0.24 [SD =  0.30] and 0.22 
[SD = 0.09] respectively), while parent proxies scored the 
EQ-5D-Y lower than the HUI3 (0.01 [SD = 0.14] and 0.16 
[SD  =  0.10] respectively). All scores were below child 
population norms: 0.89 for EQ-5D-Y [20]; 83.17 for VAS 
[20]; 0.95 for HUI2 [21, 22]; and 0.85 to 0.92 for HUI3 [8]. 
Statistical analysis of child and parent proxy dyads HRQoL 
scores
A significant effect of respondent type was found for 
all measures besides the VAS. Child self-reported 
total scores were significantly higher for the EQ-5D-Y 
(Z = −2.525, p = 0.012), HUI2 (Z = −2.310, p = 0.021) 
and HUI3 (Z  =  −2.599, p  =  0.009). Mean child VAS 
scores were higher, but not significantly (Z  =  −1.483, 
p = 0.138). See Table 3 for median score results.
Correlation between child self‑report and parent proxy 
measures
Correlation coefficients are presented in Table 4. Signifi-
cant strong (p  <  0.05) correlations were found between 
dyads of child and parent proxy results for the EQ-5D-Y 
(rs  =  0.665, p  =  0.026), HUI2 (rs  =  0.728, p  =  0.005) 
and HUI3 (rs  =  0.842, p  <  0.001). Strong significant 
Table 3 Outcome measure results and descriptive statistics (by child age group) for children with mobility impairments 
and parent proxies
a  −0.594 = minimum value, 1 = maximum value (0 = death; 1 = perfect health)
b  0 = minimum value, 100 = maximum value (0 = worst possible health; 1 = best possible health)
c  −0.03 = minimum value, 1 = maximum value (0 = death; 1 = perfect health)
d  −0.36 = minimum value, 1 = maximum value (0 = death; 1 = perfect health)
Age Child self‑report Parent proxy
6–15 16–18 All 6–15 16–18 All
EQ-5D-Ya
 Mean 0.08 0.52 0.24 0.00 0.04 0.01
 SD 0.14 0.30 0.30 0.18 0.04 0.14
 Median 0.03 0.65 0.23 0.03 0.04 0.03
 25th −0.02 0.46 0.02 −0.05 0.00 0.00
 75th 0.23 0.71 0.41 0.10 0.07 0.07
 N 7 4 11 7 4 11
VASb
 Mean 84.29 74.00 79.54 77.86 73.33 75.77
 SD 15.92 12.98 15.01 15.51 14.72 14.70
 Median 90.00 78.50 81.00 80.00 75.00 80.00
 25th 85.00 71.75 77.00 77.50 66.25 70.00
 75th 91.00 80.00 90.00 87.50 83.75 85.00
 N 7 6 13 7 6 13
HUI2c
 Mean 0.52 0.56 0.53 0.46 0.52 0.49
 SD 0.08 0.07 0.07 0.12 0.06 0.09
 Median 0.53 0.55 0.54 0.43 0.54 0.46
 25th 0.45 0.54 0.46 0.41 0.48 0.43
 75th 0.55 0.59 0.55 0.48 0.56 0.54
 N 7 6 13 7 6 13
HUI3d
 Mean 0.20 0.24 0.22 0.14 0.18 0.16
 SD 0.09 0.10 0.09 0.13 0.06 0.10
 Median 0.22 0.24 0.22 0.10 0.21 0.16
 25th 0.16 0.21 0.21 0.06 0.17 0.07
 75th 0.25 0.29 0.27 0.19 0.22 0.22
 N 7 6 13 7 6 13
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correlation was also found between the child HUI3 and 
parent proxy HUI2 (rs  =  0.567, p  =  0.043); the child 
HUI2 and parent proxy HUI3 (rs = 0.932, p < 0.001); and 
the child EQ-5D-Y and parent proxy HUI2 (rs =  0.637, 
p  =  0.039). A strong but non-significant correlation 
was found between the child and parent proxy VAS 
(rs = 0.545, p = 0.054). Therefore, convergence between 
equivalent child and parent proxy measures was suffi-
cient, with only the parent HUI3 and child HUI2 exhibit-
ing stronger correlations with non-equivalent measures.
Agreement between child self‑report and parent proxy 
measures (dyads)
Sufficient agreement was found between the child and 
parent proxy HUI2 (confidence limit [CL] = 0.22), HUI3 
(CL = 0.22) and VAS measures (CL = 0.32) (see Table 5; 
Fig. 2), with the HUI measures showing the most agree-
ment between child and parent scores. The EQ-5D-Y 
exhibited clinically important discrepancies between 
child and parent proxy responses (CL  =  1.04) thus 
showing insufficient agreement to be used interchange-
ably in this cohort. 
Discussion
The EQ-5D-Y did not sufficiently measure HRQoL in 
accordance with how the sampled children and parents 
defined overall health status. This is likely due to general 
population health state preferences being unrepresenta-
tive of how children with mobility impairments (and 
their parents by proxy) value their own health state.
The simple descriptive system of the EQ-5D-Y lacks 
nuance for children with mobility impairments. For 
instance, the EQ-5D-Y mobility domain has no consider-
ation for mobility beyond walking and thus automatically 
discounts the HRQoL of a mobility impaired child, even 
though they may be mobile using assistive technology 
solutions. The relationship between gross motor func-
tion is often contradictory [23], thus measures such as 
the EQ-5D and HUI lack sufficient sensitivity to be used 
appropriately in mobility impaired populations.
VAS mean scores were to a large extent higher than 
the other measures in this study, which raises questions 
about the validity of the HRQoL measures, in particular 
the value sets used, as the VAS is a clear indicator of self 
and proxy reported health status. Future research into 
child-specific value sets could help to improve sensitiv-
ity of HRQoL measures, however it is currently unclear 
whether young children can adequately value health 
states, or whether it is appropriate to use preference 
weights from wider society or proxy reports [24].
Previous research has similarly demonstrated the issue 
of using proxy HRQoL data, as proxy scores are often 
systematically lower than self-reports of children with 
disabilities [11, 12]. In practice child self-reported data 
should be prioritised over proxy data. In circumstances 
where this is not possible, the VAS appears to be more 
valid than the EQ-5D-Y and HUI2/3 for measuring health 
outcomes of children with mobility impairments. Further 
research should focus on establishing whether systematic 
differences between child and proxy reports can be suffi-
ciently predicted and used to adjust proxy outcomes.
Methodological considerations
Significant differences were found between child and par-
ent proxy measures, and yet they were also correlated. 
These two concepts would appear to be mutually exclu-
sive, but in fact demonstrate the issue with using just sta-
tistical analysis of respondent type effect or correlation 
to assess relationships between measures. Statistically 
significant differences in mean scores demonstrate that 
mean scores are sufficiently different to be significant, 
however this does not indicate the relationship between 
scores across the cohort. Correlation is an indication of 
Fig. 1 Mean EQ-5D-Y, VAS, HUI2 and HUI3 total scores for children 
with mobility impairments and parent proxies. Figure showing mean 
EQ-5D-Y, VAS, HUI2 and HUI3 total scores for children with mobility 
impairments and parent proxies. The EQ-5D-Y and HUI measures are 
scored on a 0 to 1 scale, while the VAS is scored on a 0 to 100 scale. 
For the purpose of this comparison, the VAS has been converted to a 
0 to 1 scale
Table 4 Correlations between child self-reported and par-
ent proxy results
* Significant correlation at 0.05 level (2-tailed)
Strength of correlation: <0.20 = absent; 0.20 to 0.35 = weak; 0.35 to 
0.50 = moderate; ≥0.50 = strong
Child EQ‑5D‑Y Child VAS Child HUI2 Child HUI3
Parent EQ-5D-Y 0.665* −0.177 0.279 −0.167
Parent VAS 0.075 0.545 −0.187 −0.298
Parent HUI2 0.627* −0.329 0.728* 0.567*
Parent HUI3 0.290 −0.537 0.932* 0.842*
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Table 5 Comparing mobility impaired child self-reported and  parent proxy outcomes: agreement, correlation 
and respondent type effect
* Significant at 0.05 level
a  Converted to 0 to 1 scale
b  Strength of correlation: <0.20 = absent; 0.20 to 0.35 = weak; 0.35 to 0.50 = moderate; ≥0.50 = strong
N (Dyads) Mean difference 95% confidence limits Overall agreement limit Wilcoxon signed rank p Spearman’s Rho cor‑
relation  coefficientb
EQ-5D-Y 11 0.24 −0.29 to 0.75 1.04 0.012* 0.665*
VASa 13 0.04 −0.12 to 0.20 0.32 0.138 0.545
HUI2 13 0.05 −0.06 to 0.15 0.22 0.021* 0.728*
HUI3 13 0.16 −0.06 to 0.18 0.22 0.009* 0.842*
Fig. 2 Bland–Altman plots: agreement between children with mobility impairments and parent proxies for EQ-5D-Y a, VAS b, HUI2 c and HUI3 d. 
On the plots 95% of differences should lie between the established limits of agreement (mean difference ± 1.96 SD), represented as dashed lines. 
Where bias or limits of agreement are beyond those deemed acceptable for clinical use, the measures lack agreement to be used interchangeably 
to measure the same construct. The EQ-5D-Y and HUI measures are scored on a 0 to 1 scale, while the VAS is scored on a 0 to 100. For the purpose 
of this comparison, the VAS has been converted to a 0 to 1 scale
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association, for instance as child scores goes up so do par-
ent scores. This, however, does not give an indication as 
to whether these scores are in agreement; a large differ-
ence between child and parent scores may exist but they 
may also vary in a similar manner, and thus still be corre-
lated. Tests of agreement should supplement analyses of 
correlation in order to gain a better understanding of the 
relationship between measures and/or respondents.
Limitations
The size of the sample was small and thus the analyses 
lacked power. Furthermore, the demographic character-
istics were not representative of the wider population of 
children with mobility impairments in the UK. Dyads 
with missing data were excluded from analyses, which 
reduced the sample size. In future research a larger sam-
pling frame is required. Comparing the results of the VAS 
with validated HRQoL measures raises some issues, as 
the VAS is not preference-based and thus does not pro-
vide an indication of the relative societal value of different 
states of health. Therefore, VAS results are not directly 
comparable with more complex preference-based meas-
ures. EuroQoL do not recommend the use of the adult 
EQ-5D value set for scoring the EQ-5D-Y. Despite these 
shortcomings, this pilot demonstrates that children with 
mobility impairments can assess their own HRQoL and 
health status, thus their views should be  prioritised in 
outcome measurement.
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